What Happened?
Research Triangle Park,, NC-based T3D-Therapeutics Appointed John Didsbury as Founder and Chief Executive Officer
About the Company
T3D Therapeutics` mission is to develop its lead drug product candidate, T3D-959, as a potential `First-in-Class`and `Best-in-Class` disease-modifying, breakthrough medicine for the treatment of Alzheimer`s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D=959 and has initiated pre-clinical studies in Huntington’s Disease models.
About the Person
John Didsbury is Founder and Chief Executive Officer at T3D Therapeutics. Previously, John held various senior HR leadership roles in the industry.
Info Source
News
Short Profile